Home > Back to Publisher > Report Information

Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Global Markets Direct
September 28, 2009
71 Pages - SKU: GMD2469433

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Taiwan

Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Taiwan drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Taiwan

Scope

The report provides information on the drug delivery devices market in Taiwan.
Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors such as Terumo Corporation, Baxter International Inc., JMS CO., LTD., Fresenius Kabi AG, and B. Braun Melsungen AG.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in Taiwan.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report: 3.1 Drug delivery devices; 3.2 Inhalation Systems; 3.3 Infusion Systems
4 Healthcare Sector Review: 4.1 Healthcare Expenditure; 4.2 Healthcare Infrastructure; 4.3 Healthcare Policy
5 Regulation System: 5.1 Medical Equipment Approval Process; 5.2 Pre-market Approval; 5.3 Fast-track Approval; 5.4 Registration Period; 5.5 Labeling and Packaging; 5.6 Post-market Surveillance
6 Pricing and Reimbursement: 6.1 Reimbursement Application; 6.2 Reimbursement Systems
7 Distribution Structure
8 Drug Delivery Devices In Taiwan: 8.1 Drug Delivery Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015; 8.2 Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), 2000-2015; 8.3 Drug Delivery Devices, Taiwan, Category Volume (Units), 2000-2015; 8.4 Drug Delivery Devices, Taiwan, Company Share (2007-2008)
9 Infusion Systems In Taiwan: 9.1 Infusion Systems Overall Revenue (2000-2015); 9.2 Infusion Systems Overall Volume (2000-2015); 9.3 Infusion Systems Average Price (2000-2015); 9.4 Infusion Systems Distribution Share (2007-2008); 9.5 Infusion Systems, Taiwan, Company Share (2007-2008)
10 Inhalation Systems In Taiwan: 10.1 Inhalation Systems Overall Revenue (2000-2015); 10.2 Inhalation Systems Overall Volume (2000-2015); 10.3 Inhalation Systems Average Price (2000-2015); 10.4 Inhalation Systems Distribution Share (2007-2008); 10.5 Inhalation Systems, Taiwan, Company Share (2007-2008)
11 Overview of Key Companies in Taiwan Drug Delivery Devices Market: 11.1 AstraZeneca PLC; 11.2 Boehringer Ingelheim GmbH; 11.3 Baxter International Inc.; 11.4 Novartis AG; 11.5 Terumo Corporation; 11.6 Cardinal Health, Inc.; 11.7 GlaxoSmithKline plc; 11.8 B. Braun Melsungen AG; 11.9 Smiths Medical; 11.10 Fresenius Kabi AG; 11.11 Consort Medical plc; 11.12 Hospira, Inc.
12 Financial Deals Landscape: 12.1 Partnerships
13 Appendix: 13.1 Global Markets Direct Research Methodology; 13.2 Secondary Research; 13.3 Primary Research; 13.4 Models; 13.5 Forecasts; 13.6 Expert Panel Validation; 13.7 Currency Conversion; 13.8 Contact Us; 13.9 Disclaimer
1.1 List of Tables: Table 1: Healthcare Expenditure in Taiwan, 2004-2008; Table 2: Public and private Hospitals in Taiwan, 2004; Table 3: Healthcare Personnel per 10,000 Population by Locality in Taiwan, 2005; Table 4: Specialty Beds in Hospitals by Accreditation in Taiwan, 2005; Table 5: Specialty Beds in Hospitals by Accreditation in Taiwan, 2005; Table 6: Medical Equipment Pre-market Approval in Taiwan, 2007; Table 7: Medical Equipment Evaluation Standards in Taiwan, 2007; Table 8: Drug Delivery Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015; Table 9: Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), 2000-2015; Table 10: Drug Delivery Devices, Taiwan, Cross-Category Analysis, 2000-2015; Table 11: Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), Historic, 2000-2008; Table 12: Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), Forecast, 2008-2015; Table 13: Drug Delivery Devices, Taiwan, Category Volume (Units), 2000-2015; Table 14: Drug Delivery Devices, Taiwan, Category Volume (Units), Historic, 2000-2008; Table 15: Drug Delivery Devices, Taiwan, Category Volume (Units), Forecast, 2008-2015; Table 16: Drug Delivery Devices, Taiwan, Company Share by Revenue ($ mn), 2007-2008; Table 17: Infusion Systems, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008; Table 18: Infusion Systems, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015; Table 19: Infusion Systems, Taiwan, Volume (Units) by Segment, Historic, 2000-2008; Table 20: Infusion Systems, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015; Table 21: Infusion Systems, Taiwan, Average Price ($), Historic, 2000-2008; Table 22: Infusion Systems, Taiwan, Average Price ($), Forecast, 2008-2015; Table 23: Infusion Systems, Taiwan, Distribution Share by Revenue ($mn), 2007-2008; Table 24: Infusion Systems, Taiwan, Company Share by Revenue ($ mn), 2007-2008; Table 25: Inhalation Systems, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008; Table 26: Inhalation Systems, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015; Table 27: Inhalation Systems, Taiwan, Volume (Units) by Segment, Historic, 2000-2008; Table 28: Inhalation Systems, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015; Table 29: Inhalation Systems, Taiwan, Average Price ($), Historic, 2000-2008; Table 30: Inhalation Systems, Taiwan, Average Price ($), Forecast, 2008-2015; Table 31: Inhalation Systems, Taiwan, Distribution Share by Revenue ($mn), 2007-2008; Table 32: Inhalation Systems, Taiwan, Company Share by Revenue ($ mn), 2007-2008; Table 33: Terumo Corporation Pipeline Products by Equipment Type; Table 34: Terumo Corporation Pipeline Products By Development Stage; Table 35: Terumo Corporation Pipeline Products By Therapy Area; Table 36: Terumo Corporation Pipeline Products By Clinical Trials; Table 37: Terumo Corporation Pipeline Products By News Summary; Table 38: Bespak plc Pipeline Products by Equipment Type; Table 39: Bespak plc Pipeline Products By Development Stage; Table 40: Bespak plc Pipeline Products By Therapy Area; Table 41: Novartis Terminates Its Licensing Agreement With NexMed; Table 42: Teikoku Pharma Enters Into An Agreement With Eisai; Table 43: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures: Figure 1: Healthcare Expenditure in Taiwan, 2004-2008; Figure 2: Medical Equipment Pre-Market Approval Process in Taiwan, 2007; Figure 3: Medical Equipment Reimbursement Process in Taiwan, 2007; Figure 4 Drug Delivery Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015; Figure 5 Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), 2000-2015; Figure 6 Drug Delivery Devices, Taiwan, Cross-Category Analysis, 2000-2015; Figure 7 Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), Historic, 2000-2008; Figure 8 Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), Forecast, 2008-2015; Figure 9 Drug Delivery Devices, Taiwan, Category Volume (Units), 2000-2015; Figure 10 Drug Delivery Devices, Taiwan, Category Volume (Units), Historic, 2000-2008; Figure 11 Drug Delivery Devices, Taiwan, Category Volume (Units), Forecast, 2008-2015; Figure 12 Drug Delivery Devices, Taiwan, Company Share (%), 2008; Figure 13 Infusion Systems, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008; Figure 14 Infusion Systems, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015; Figure 15 Infusion Systems, Taiwan, Company Share (%), 2008; Figure 16 Inhalation Systems, Taiwan, Revenue ($ mn) by Segment, Historic, 2000-2008; Figure 17 Inhalation Systems, Taiwan, Revenue ($ mn) by Segment, Forecast, 2008-2015; Figure 18 Inhalation Systems, Taiwan, Volume (Units) by Segment, Historic, 2000-2008; Figure 19 Inhalation Systems, Taiwan, Volume (Units) by Segment, Forecast, 2008-2015; Figure 20 Inhalation Systems, Taiwan, Company Share (%), 2008; Figure 21 Global Markets Direct Methodology

More Taiwan Reports

D&B Country RiskLine Report: Taiwan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering ...

D&B Country Report: Taiwan by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

2007 Taiwan Industry & Market Outlook by Barnes Reports
The 2007 Taiwan Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Taiwan and 500+ minor industries ...

The 2005 Taiwan Economic and Product Market Databook by Icon Group International, Inc.
Market Potential Estimation Methodology Overview This study covers the outlook products in Taiwan. For the year reported, estimates are given for the latent demand, or ...

See all reports like this >>

Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service